1. Wilkinson SM. Hypersensitivity to topical and systemic corticosteroids: a review. Clin Exp Dermatol. 1994;19: 1--11. 2. Baeck M, Marot L, Nicolas JF, Pilette C, Tennstedt D, Goossens A. Allergic hypersensitivity to topical and systemic corticosteroids: a review. Allergy. 2009;64: 978--94. 3. Matura M, Goossens A. Contact allergy to corticosteroids. Allergy. 2000;55:698--704. 4. Soria A, Baec...

1. Textiles and shoes. In: Fisher’s contact dermatitis. 6th ed. Hamilton, Ontario: Bc Decker Inc.; 2008. p. 339--69. 2. Warshaw EM, Schram SE, Belsito DV, DeLeo VA, Fowler Jr JF, Maibach HI, et al. Shoe allergens: retrospective analysis of cross-sectional data from the North American contact dermatitis group, 2001--2004. Dermatitis. 2007;18:191. 3. Fleming AJ. The provocative test for assaying ...

Morbihan disease is a rare condition characterized by chronic and persistent erythematous solid edema localized on the face. It is believed to be a complication of rosacea and may occur at any stage of the disease. Features of this condition include variable therapeutic response and great refractoriness. We report a case of a 61-year-old man with rosacea history diagnosed with Morbihan disease,...

We compare the clinical course of 74 boys 10–18 years of age with Duchenne muscular dystrophy (DMD) treated (40) and not treated (34) with deflazacort. Treated boys were able to rise from supine to standing, climb stairs and walk 10 m without aids, 3–5 years longer than boys not treated. After 10 years of age, treated boys had significantly better pulmonary function than boys not treated and af...

BACKGROUND To evaluate cardiovascular function in boys with Duchenne (DMD) and Becker (BMD) muscular dystrophy, using cardiac magnetic resonance (CMR). METHODS This is a single point cross sectional study of twenty-four boys with genetically ascertained DMD, and 10 with BMD, aged 10.5 ± 1.5 years (range 9-13), were prospectively evaluated by a 1.5 T system and compared with those of age-sex m...

We compare the clinical course of 74 boys 10-18 years of age with Duchenne muscular dystrophy (DMD) treated (40) and not treated (34) with deflazacort. Treated boys were able to rise from supine to standing, climb stairs and walk 10 m without aids, 3-5 years longer than boys not treated. After 10 years of age, treated boys had significantly better pulmonary function than boys not treated and af...

BACKGROUND Supernatants from epithelial cell cultures enhance eosinophil survival in vitro, this effect being abrogated by previous incubation of eosinophils with glucocorticosteroids. This property has resulted in the development of an in vitro test to compare the potency of these drugs. A comparative study was performed with dexamethasone, methylprednisolone, deflazacort, and budesonide. ME...